Cargando…

Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer

Chemotherapy has become the global standard treatment for patients with metastatic or unresectable gastric cancer (GC), although outcomes remain unfavorable. Many molecular-targeted therapies inhibiting signaling pathways of various tyrosine kinase receptors have been developed, and monoclonal antib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inokuchi, Mikito, Fujimori, Yoshitaka, Otsuki, Sho, Sato, Yuya, Nakagawa, Masatoshi, Kojima, Kazuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427097/ https://www.ncbi.nlm.nih.gov/pubmed/26000013 http://dx.doi.org/10.1155/2015/796380

Ejemplares similares

Impact of comorbidities on postoperative complications in patients undergoing laparoscopy-assisted gastrectomy for gastric cancer
por: Inokuchi, Mikito, et al.
Publicado: (2014)

Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancer
por: Inokuchi, Mikito, et al.
Publicado: (2017)

Prognostic value of RKIP and p-ERK in gastric cancer
por: Fujimori, Yoshitaka, et al.
Publicado: (2012)

TPX2 expression is associated with poor survival in gastric cancer
por: Tomii, Chiharu, et al.
Publicado: (2017)

High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival
por: Nasri, Baongoc, et al.
Publicado: (2017)

Postoperative Complications of Laparoscopic Total Gastrectomy versus Open Total Gastrectomy for Gastric Cancer in a Meta-Analysis of High-Quality Case-Controlled Studies
por: Inokuchi, Mikito, et al.
Publicado: (2016)

Clinical significance of platelet derived growth factor-C and -D in gastric cancer
por: OGAWA, NORIHITO, et al.
Publicado: (2015)

EphA4 is a prognostic factor in gastric cancer
por: Miyazaki, Kohji, et al.
Publicado: (2013)

Feasibility of laparoscopic total gastrectomy in overweight patients: Implications of less impact of overweight on laparoscopic versus open approach
por: Nakagawa, Masatoshi, et al.
Publicado: (2018)

Fibroblast growth factor receptor signaling as therapeutic targets in female reproductive system cancers
por: Zhu, Dong-Li, et al.
Publicado: (2020)

Fibroblast Growth Factor Receptor 4 Targeting in Cancer: New Insights into Mechanisms and Therapeutic Strategies †
por: Lang, Liwei, et al.
Publicado: (2019)

Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
por: Krook, Melanie A., et al.
Publicado: (2020)

Fibroblast Growth Factor Receptors as Novel Therapeutic Targets in SNF5-Deleted Malignant Rhabdoid Tumors
por: Wöhrle, Simon, et al.
Publicado: (2013)

A case of conservatively managed gastric perforation at a recurrent hiatal hernia site after laparoscopic paraesophageal repair
por: Ogo, Taichi, et al.
Publicado: (2023)

Targeting fibroblast growth factor receptors to combat aggressive ependymoma
por: Lötsch, Daniela, et al.
Publicado: (2021)

A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors
por: Fukamachi, Hiroshi, et al.
Publicado: (2019)

Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy
por: Szlachcic, Anna, et al.
Publicado: (2016)

Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives
por: Tokunaga, Masanori, et al.
Publicado: (2019)

Correction to: Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives
por: Tokunaga, Masanori, et al.
Publicado: (2020)

Dislocation of the gastric conduit reconstructed via the posterior mediastinal route is a significant risk factor for anastomotic disorder after McKeown esophagectomy
por: Nakajima, Masanobu, et al.
Publicado: (2021)

Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting
por: Cheng, Tiewei, et al.
Publicado: (2013)

Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer
por: Jain, Vikram K, et al.
Publicado: (2012)

Rationale for targeting fibroblast growth factor receptor signaling in breast cancer
por: André, Fabrice, et al.
Publicado: (2015)

Construction and characterization of immunoliposomes targeting fibroblast growth factor receptor 3
por: Zheng, Zhong, et al.
Publicado: (2019)

Mechanisms of acquired resistance to fibroblast growth factor receptor targeted therapy
por: Lau, David K., et al.
Publicado: (2019)

Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer
por: Pacini, Laura, et al.
Publicado: (2021)

Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer
por: Francavilla, Chiara, et al.
Publicado: (2022)

Fast Growing Furious Races for Targeting Fibroblast Growth Factor Receptors
por: Park, Daechan
Publicado: (2022)

Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland
por: Doddapaneni, Ravi, et al.
Publicado: (2019)

Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma
por: Narisawa, Takafumi, et al.
Publicado: (2023)

Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer
por: Kawano, Takahito, et al.
Publicado: (2022)

Therapeutic effects of thalidomide in myeloma are associated with the expression of fibroblast growth factor receptor 3
por: Qian, Shenxian, et al.
Publicado: (2005)

Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer
por: Chang, Jinjia, et al.
Publicado: (2014)

Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
por: Kodama, Yuta, et al.
Publicado: (2021)

Targeting fibroblast growth factors in cancer
por: Baker, Kevin P., et al.
Publicado: (2013)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
por: Sobhani, Navid, et al.
Publicado: (2018)

Importance of Translational Research for Targeting Fibroblast Growth Factor Receptor Signaling in Cancer
por: Holzmann, Klaus, et al.
Publicado: (2019)

Fibroblast growth factor receptors as targets for anticancer therapy in cholangiocarcinomas and urothelial carcinomas
por: Wekking, Demi, et al.
Publicado: (2023)

Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer
por: Wang, Hao, et al.
Publicado: (2022)

Fibroblast Growth Factors and Vascular Endothelial Growth Factor Promote Cardiac Reprogramming under Defined Conditions
por: Yamakawa, Hiroyuki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bh3656rhg7af2igr0me2jgjck2